Morgan Stanley Theratechnologies Inc. Transaction History

Morgan Stanley

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.01 $72,228 - $93,526	92,600 Added 1.18%	7,952,103 $6.68 Million
Q1 2023 May 15, 2023	SELL	$0.72 - $1.12 $12,888 - $20,048	-17,900 Reduced 0.23%	7,859,503 $6.37 Million
Q4 2022 Feb 14, 2023	BUY	$0.83 - $2.3 $202,599 - $561,420	244,096 Added 3.2%	7,877,403 $6.93 Million
Q3 2022 Nov 14, 2022	BUY	$1.98 - $2.42 $414,869 - $507,062	209,530 Added 2.82%	7,633,307 $18.1 Million
Q2 2022 Oct 27, 2022	BUY	$2.21 - $2.7 $1.85 Million - $2.26 Million	837,926 Added 12.72%	7,423,777 $16.9 Million

Q2 2022 Aug 15, 2022	BUY	$2.21 - $2.7 $1.85 Million - $2.26 Million	837,926 Added 12.72%	7,423,777 $16.9 Million
Q1 2022 Oct 27, 2022	SELL	$2.37 - $3.24 $1.99 Million - $2.71 Million	-837,926 Reduced 11.29%	6,585,851 $16.1 Million
Q1 2022 May 13, 2022	BUY	$2.37 - $3.24 $3.42 Million - $4.67 Million	1,442,830 Added 28.05%	6,585,851 $16.1 Million
Q4 2021 Feb 14, 2022	BUY	$2.92 - $3.76 $3.27 Million - $4.21 Million	1,120,328 Added 27.85%	5,143,021 $15.6 Million
Q3 2021 Nov 15, 2021	BUY	$3.28 - $4.07 $13.2 Million - $16.4 Million	4,022,693 New	4,022,693 $15.1 Million

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $135M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.